Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Mismatch Repair01:20

Mismatch Repair

6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral Prophylactic and Contralateral Risk-Reducing Mastectomy in Women With Germline CDH1 Pathogenic or Likely-Pathogenic Variants.

Journal of surgical oncology·2026
Same author

Germline Multigene Panel Testing in Women With Invasive Lobular Cancer.

JAMA network open·2026
Same authorSame journal

European Cancer Prevention Organization on cancer screening: an expert panel position paper.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2026
Same author

Comment on: "Robotic and Endoscopic Minimally Invasive Breast Surgery: A Narrative Synthesis on Divergent Global Adoption and Emerging Trends".

European journal of breast health·2026
Same author

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools.

La Radiologia medica·2026

Related Experiment Video

Updated: Mar 6, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

15.1K

BRCA1/2 germline missense mutations: a systematic review.

Giovanni Corso1, Irene Feroce2, Mattia Intra1

  • 1Division of Surgical Senology.

European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|March 10, 2017
PubMed
Summary

This systematic review identifies 61 pathogenic BRCA1/2 germline missense mutations, crucial for understanding hereditary breast and ovarian cancer risks. Findings aid in managing carriers and their families.

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.7K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

15.1K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.7K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.0K

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Hereditary breast and ovarian cancer (HBOC) is linked to BRCA1/2 germline mutations.
  • Missense variants in BRCA1/2 pose diagnostic challenges due to unclear pathogenicity.
  • Understanding these mutations is vital for genetic counseling and risk assessment.

Purpose of the Study:

  • To systematically review and compile pathogenic BRCA1/2 germline missense mutations.
  • To analyze mutation distribution and functional impact within BRCA1 and BRCA2 genes.
  • To enhance the clinical management of HBOC patients and their relatives.

Main Methods:

  • Systematic literature review adhering to the PRISMA statement.
  • Inclusion of English-language articles from MEDLINE.
  • Focus on BRCA1/2 germline missense mutations in breast and ovarian cancer patients.

Main Results:

  • Identified 61 pathogenic BRCA1/2 germline missense mutations.
  • 70.5% of mutations affected BRCA1, primarily in the C-terminus (48.8%).
  • European populations showed higher rates of BRCA1 mutations; Asian populations, BRCA2.

Conclusions:

  • Pathogenic BRCA1/2 missense mutations require specific genetic testing for accurate assessment.
  • This review provides a comprehensive dataset to improve HBOC management.
  • Further research into novel missense mutations is essential for clinical application.